Vista Pharmaceuticals Ltd. - Research Center
524711 VISTAPH Group (Z) BSE data
Add to watchlist
| Results |
Annual
|
| Statement | |
| More |
Annual results in brief
(Rs crore)
| Mar ' 24 | Mar ' 23 | Mar ' 22 | Mar ' 21 | Mar ' 20 | |
|---|---|---|---|---|---|
| Sales | 10.29 | 1.00 | 0.39 | 1.27 | 22.76 |
| Operating profit | -3.57 | -2.22 | -1.21 | -1.73 | -4.80 |
| Interest | 1.22 | 1.21 | 0.90 | 1.55 | 1.54 |
| Gross profit | -4.46 | -3.15 | -1.94 | -2.96 | -2.59 |
| EPS (Rs) | -0.96 | -1.58 | -0.23 | -0.51 | -1.21 |
Annual
results in details
| Mar ' 24 | Mar ' 23 | Mar ' 22 | Mar ' 21 | Mar ' 20 | |
|---|---|---|---|---|---|
| Other income | 0.33 | 0.29 | 0.17 | 0.32 | 3.75 |
| Stock adjustment | 0.01 | - | - | - | 1.04 |
| Raw material | 8.88 | 1.23 | 0.37 | 0.73 | 22.90 |
| Power and fuel | - | - | - | - | - |
| Employee expenses | 1.79 | 0.58 | 0.57 | 1.15 | 1.49 |
| Excise | - | - | - | - | - |
| Admin and selling expenses | - | - | - | - | - |
| Research and development expenses | - | - | - | - | - |
| Expenses capitalised | - | - | - | - | - |
| Other expenses | 3.17 | 1.41 | 0.66 | 1.11 | 2.13 |
| Provisions made | - | - | - | - | - |
| Depreciation | 0.72 | 1.57 | 0.62 | 0.73 | 1.35 |
| Taxation | -0.67 | 1.09 | -1.73 | -1.80 | -0.26 |
| Net profit / loss | -4.51 | -5.82 | -0.83 | -1.89 | -3.68 |
| Extra ordinary item | - | - | - | - | - |
| Prior year adjustments | - | - | - | - | - |
| Equity capital | 9.43 | 7.36 | 7.36 | 7.36 | 6.07 |
| Equity dividend rate | - | - | - | - | - |
| Agg.of non-prom. shares (Lacs) | - | - | - | - | - |
| Agg.of non promotoholding (%) | - | - | - | - | - |
| OPM (%) | -34.71 | -221.31 | -306.77 | -136.58 | -21.08 |
| GPM (%) | -41.97 | -244.28 | -347.06 | -186.77 | -9.77 |
| NPM (%) | -42.48 | -451.22 | -148.46 | -118.95 | -13.87 |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis